JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Pfizer
PFE
|
+$919M |
| 3 |
Microsoft
MSFT
|
+$718M |
| 4 |
Wells Fargo
WFC
|
+$679M |
| 5 |
PepsiCo
PEP
|
+$641M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.62B |
| 2 |
Johnson & Johnson
JNJ
|
+$1.19B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$754M |
| 4 |
Booking.com
BKNG
|
+$726M |
| 5 |
SLB Ltd
SLB
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.42% |
| 2 | Financials | 13.44% |
| 3 | Healthcare | 11.49% |
| 4 | Technology | 10.73% |
| 5 | Consumer Discretionary | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
SLR Investment Corp
SLRC
$637M
| $5.83M | ﹤0.01% |
287,969
+10,086
| +4% | +$196K |
2013 Q2
7 quarters
|
|
|
DST
2127
DELISTED
DST Systems Inc.
DST
| $5.83M | ﹤0.01% |
105,228
-119,018
| -53% | -$6.12M |
2013 Q2
7 quarters
|
|
2128
Stratasys
SSYS
$747M
| $5.82M | ﹤0.01% |
110,234
+26,249
| +31% | +$1.74M |
2013 Q3
6 quarters
|
|
2129
CDW
CDW
$17B
| $5.8M | ﹤0.01% |
155,838
-28,264
| -15% | -$1.03M |
2013 Q3
6 quarters
|
|
|
ENLC
2130
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.79M | ﹤0.01% |
178,135
+132,815
| +293% | +$4.4M |
2013 Q2
7 quarters
|
|
2131
WSFS Financial
WSFS
$3.91B
| $5.77M | ﹤0.01% |
229,026
-11,697
| -5% | -$298K |
2013 Q2
7 quarters
|
|
2132
CALL
MiMedx Group
MDXG
$677M
| $5.72M | ﹤0.01% |
550,000
+50,000
| +10% | +$468K |
2014 Q4
1 quarter
|
|
2133
Azenta
AZTA
$1.51B
| $5.71M | ﹤0.01% |
490,505
+57,175
| +13% | +$701K |
2013 Q2
7 quarters
|
|
2134
Matrix Service
MTRX
$296M
| $5.7M | ﹤0.01% |
324,225
+80,868
| +33% | +$1.52M |
2013 Q2
7 quarters
|
|
2135
PTC Therapeutics
PTCT
$5.35B
| $5.68M | ﹤0.01% |
93,375
+17,638
| +23% | +$1.08M |
2014 Q3
2 quarters
|
|
|
EFT
2136
Eaton Vance Floating-Rate Income Trust
EFT
$285M
| $5.68M | ﹤0.01% |
389,350
-5,829
| -1% | -$82.7K |
2013 Q4
5 quarters
|
|
|
HOS
2137
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $5.68M | ﹤0.01% |
301,810
+138,216
| +84% | +$2.88M |
2013 Q2
7 quarters
|
|
2138
Booz Allen Hamilton
BAH
$8.48B
| $5.67M | ﹤0.01% |
195,922
-548,622
| -74% | -$16M |
2013 Q2
7 quarters
|
|
2139
Rithm Capital
RITM
$4.89B
| $5.66M | ﹤0.01% |
376,786
+301,912
| +403% | +$4.17M |
2013 Q2
7 quarters
|
|
2140
CALL
Chevron
CVX
$406B
| $5.66M | ﹤0.01% |
53,886
-345,578
| -87% | -$36.9M |
2014 Q3
2 quarters
|
|
2141
CALL
American Express
AXP
$204B
| $5.65M | ﹤0.01% |
72,322
+57,222
| +379% | +$4.75M |
2014 Q3
2 quarters
|
|
2142
PUT
Flowserve
FLS
$9.29B
| $5.65M | ﹤0.01% |
+100,000
| New | +$5.8M |
2015 Q1
0 quarters
|
|
|
IPXL
2143
DELISTED
Impax Laboratories, Inc.
IPXL
| $5.63M | ﹤0.01% |
120,126
-208,900
| -63% | -$8.31M |
2013 Q2
7 quarters
|
|
2144
CONMED
CNMD
$1.38B
| $5.63M | ﹤0.01% |
111,487
-43,775
| -28% | -$2.15M |
2013 Q2
7 quarters
|
|
2145
KKR & Co
KKR
$81.9B
| $5.63M | ﹤0.01% |
246,665
-1,430,382
| -85% | -$33.8M |
2013 Q2
7 quarters
|
|
2146
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
| $5.62M | ﹤0.01% |
101,476
+56,732
| +127% | +$3.13M |
2013 Q2
7 quarters
|
|
|
ACOR
2147
DELISTED
Acorda Therapeutics
ACOR
| $5.61M | ﹤0.01% |
1,406
+1,140
| +429% | +$5.22M |
2014 Q2
3 quarters
|
|
2148
Avis
CAR
$3.75B
| $5.61M | ﹤0.01% |
95,055
-52,969
| -36% | -$3.23M |
2013 Q2
7 quarters
|
|
2149
Foster
FSTR
$382M
| $5.61M | ﹤0.01% |
118,156
-12,244
| -9% | -$581K |
2013 Q2
7 quarters
|
|
2150
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $5.61M | ﹤0.01% |
47,448
-333
| -0.7% | -$37.6K |
2013 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2015 Portfolio in Review
As of Q1 2015, JP Morgan Chase held 4,553 positions worth $439B, up 0.39% from $437B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2015 filing shows 344 new, 1,711 increased, 1,692 reduced and 516 closed positions. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M. The largest sale was iShares MSCI EAFE ETF, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2015 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2015 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.62B.
- JP Morgan Chase fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 16% of its $439B portfolio in Q1 2015.
- JP Morgan Chase opened 344 new positions and closed 516 in Q1 2015.
- JP Morgan Chase's portfolio value rose 0.39% quarter-over-quarter to $439B.
Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.